
Transcatheter Aortic Valve Implantation to Treat Degenerated Aortic, Mitral and Tricuspid Bioprosthesis
Transcatheter aortic valve implantation (TAVI) is now a widely accepted treatment for a broad range of patients with aortic valve stenosis, including those at low surgical risk and with previously contraindicated conditions like bicuspid valves. It has also evolved to treat degenerated bioprosthetic valves in the aortic, mitral, and tricuspid positions, offering an alternative to redo surgery.